Psychedelic Policy & Law in 2022 By admin - February 21, 2023 42 Source RELATED ARTICLESMORE FROM AUTHOR Pα+ Psychedelic Bulletin #169: Brin Backs Soneira, But Patent Questions Loom Large; J&J Seeks Spravato Monotherapy Approval; Canadian Study to Parse Out Role of... Psychedelics in Palliative Care: Screening, Safety Measures, and Experiences With the Divine When Data Meets Doubt: Investigating the FDA Panel’s Rejection of MDMA